Cargando…

Blockade of c-Met-Mediated Signaling Pathways by E7050 Suppresses Growth and Promotes Apoptosis in Multidrug-Resistant Human Uterine Sarcoma Cells

E7050 is a potent inhibitor of c-Met receptor tyrosine kinase and has potential for cancer therapy. However, the underlying molecular mechanism involved in the anti-cancer property of E7050 has not been fully elucidated. The main objective of this study was to investigate the anti-tumor activity of...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Tsung-Teng, Chen, Chuan-Mu, Lan, Ying-Wei, Lin, Song-Shu, Choo, Kong-Bung, Chong, Kowit-Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9740914/
https://www.ncbi.nlm.nih.gov/pubmed/36499211
http://dx.doi.org/10.3390/ijms232314884
_version_ 1784848185657655296
author Huang, Tsung-Teng
Chen, Chuan-Mu
Lan, Ying-Wei
Lin, Song-Shu
Choo, Kong-Bung
Chong, Kowit-Yu
author_facet Huang, Tsung-Teng
Chen, Chuan-Mu
Lan, Ying-Wei
Lin, Song-Shu
Choo, Kong-Bung
Chong, Kowit-Yu
author_sort Huang, Tsung-Teng
collection PubMed
description E7050 is a potent inhibitor of c-Met receptor tyrosine kinase and has potential for cancer therapy. However, the underlying molecular mechanism involved in the anti-cancer property of E7050 has not been fully elucidated. The main objective of this study was to investigate the anti-tumor activity of E7050 in multidrug-resistant human uterine sarcoma MES-SA/Dx5 cells in vitro and in vivo, and to define its mechanisms. Our results revealed that E7050 reduced cell viability of MES-SA/Dx5 cells, which was associated with the induction of apoptosis and S phase cell cycle arrest. Additionally, E7050 treatment significantly upregulated the expression of Bax, cleaved PARP, cleaved caspase-3, p21, p53 and cyclin D1, while it downregulated the expression of survivin and cyclin A. On the other hand, the mechanistic study demonstrated that E7050 inhibited the phosphorylation of c-Met, Src, Akt and p38 in HGF-stimulated MES-SA/Dx5 cells. Further in vivo experiments showed that treatment of athymic nude mice carrying MES-SA/Dx5 xenograft tumors with E7050 remarkably suppressed tumor growth. E7050 treatment also decreased the expression of Ki-67 and p-Met, and increased the expression of cleaved caspase-3 in MES-SA/Dx5 tumor sections. Therefore, E7050 is a promising drug that can be developed for the treatment of multidrug-resistant uterine sarcoma.
format Online
Article
Text
id pubmed-9740914
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-97409142022-12-11 Blockade of c-Met-Mediated Signaling Pathways by E7050 Suppresses Growth and Promotes Apoptosis in Multidrug-Resistant Human Uterine Sarcoma Cells Huang, Tsung-Teng Chen, Chuan-Mu Lan, Ying-Wei Lin, Song-Shu Choo, Kong-Bung Chong, Kowit-Yu Int J Mol Sci Article E7050 is a potent inhibitor of c-Met receptor tyrosine kinase and has potential for cancer therapy. However, the underlying molecular mechanism involved in the anti-cancer property of E7050 has not been fully elucidated. The main objective of this study was to investigate the anti-tumor activity of E7050 in multidrug-resistant human uterine sarcoma MES-SA/Dx5 cells in vitro and in vivo, and to define its mechanisms. Our results revealed that E7050 reduced cell viability of MES-SA/Dx5 cells, which was associated with the induction of apoptosis and S phase cell cycle arrest. Additionally, E7050 treatment significantly upregulated the expression of Bax, cleaved PARP, cleaved caspase-3, p21, p53 and cyclin D1, while it downregulated the expression of survivin and cyclin A. On the other hand, the mechanistic study demonstrated that E7050 inhibited the phosphorylation of c-Met, Src, Akt and p38 in HGF-stimulated MES-SA/Dx5 cells. Further in vivo experiments showed that treatment of athymic nude mice carrying MES-SA/Dx5 xenograft tumors with E7050 remarkably suppressed tumor growth. E7050 treatment also decreased the expression of Ki-67 and p-Met, and increased the expression of cleaved caspase-3 in MES-SA/Dx5 tumor sections. Therefore, E7050 is a promising drug that can be developed for the treatment of multidrug-resistant uterine sarcoma. MDPI 2022-11-28 /pmc/articles/PMC9740914/ /pubmed/36499211 http://dx.doi.org/10.3390/ijms232314884 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Huang, Tsung-Teng
Chen, Chuan-Mu
Lan, Ying-Wei
Lin, Song-Shu
Choo, Kong-Bung
Chong, Kowit-Yu
Blockade of c-Met-Mediated Signaling Pathways by E7050 Suppresses Growth and Promotes Apoptosis in Multidrug-Resistant Human Uterine Sarcoma Cells
title Blockade of c-Met-Mediated Signaling Pathways by E7050 Suppresses Growth and Promotes Apoptosis in Multidrug-Resistant Human Uterine Sarcoma Cells
title_full Blockade of c-Met-Mediated Signaling Pathways by E7050 Suppresses Growth and Promotes Apoptosis in Multidrug-Resistant Human Uterine Sarcoma Cells
title_fullStr Blockade of c-Met-Mediated Signaling Pathways by E7050 Suppresses Growth and Promotes Apoptosis in Multidrug-Resistant Human Uterine Sarcoma Cells
title_full_unstemmed Blockade of c-Met-Mediated Signaling Pathways by E7050 Suppresses Growth and Promotes Apoptosis in Multidrug-Resistant Human Uterine Sarcoma Cells
title_short Blockade of c-Met-Mediated Signaling Pathways by E7050 Suppresses Growth and Promotes Apoptosis in Multidrug-Resistant Human Uterine Sarcoma Cells
title_sort blockade of c-met-mediated signaling pathways by e7050 suppresses growth and promotes apoptosis in multidrug-resistant human uterine sarcoma cells
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9740914/
https://www.ncbi.nlm.nih.gov/pubmed/36499211
http://dx.doi.org/10.3390/ijms232314884
work_keys_str_mv AT huangtsungteng blockadeofcmetmediatedsignalingpathwaysbye7050suppressesgrowthandpromotesapoptosisinmultidrugresistanthumanuterinesarcomacells
AT chenchuanmu blockadeofcmetmediatedsignalingpathwaysbye7050suppressesgrowthandpromotesapoptosisinmultidrugresistanthumanuterinesarcomacells
AT lanyingwei blockadeofcmetmediatedsignalingpathwaysbye7050suppressesgrowthandpromotesapoptosisinmultidrugresistanthumanuterinesarcomacells
AT linsongshu blockadeofcmetmediatedsignalingpathwaysbye7050suppressesgrowthandpromotesapoptosisinmultidrugresistanthumanuterinesarcomacells
AT chookongbung blockadeofcmetmediatedsignalingpathwaysbye7050suppressesgrowthandpromotesapoptosisinmultidrugresistanthumanuterinesarcomacells
AT chongkowityu blockadeofcmetmediatedsignalingpathwaysbye7050suppressesgrowthandpromotesapoptosisinmultidrugresistanthumanuterinesarcomacells